Key Stocks to Watch This Thursday: Exail Technologies, Mersen, Valneva, and 7 Others Release Their Results
This Thursday, ten listed companies are publishing or have published their annual or semi-annual results. Here's an overview of the stocks to watch before the market opens.
Yesterday's Announcements
Exail Technologies revealed its annual 2025 results yesterday, which propelled the stock up by 6.05% in the last session. As a specialist in navigation and defense technologies, the group reported record growth, although industrial execution challenges somewhat marred the overall picture. Also yesterday, Mersen presented its annual 2025 accounts, with no notable movement in the stock at close. The specialist in materials and equipment for extreme environments saw its net result plummet by 76%, affected by a depreciation of 45 million euros. In a challenging context, Valneva published its annual 2025 results yesterday, with the stock ending the session up by 1.91%. The vaccine laboratory recorded an operational loss of 82 million euros for the past fiscal year. Also among yesterday's releases, Bastide le Confort unveiled its semi-annual 2025-2026 results, with a 2.50% increase in share price during the last session. As a leading player in the distribution of home medical equipment, the group will be scrutinized for the robustness of its organic growth in a sector under tariff pressure. In the industrial realm, Drone Volt also released its annual 2025 results yesterday, to relative market indifference, with the stock losing only 0.57%. As a French pioneer in professional drones, the company remains under observation regarding its path to profitability. It was a busy day as well for Mr Bricolage, which presented its annual 2025 accounts yesterday, with the stock settling at 4.80 euros at close. As a specialized retail chain in DIY, the group operates in a context of ongoing domestic consumption pressure.
This Morning's Announcements
This Thursday morning, Wallix is publishing its annual 2025 results, after the stock had fallen by 4.15% in the last session. As a specialist in cybersecurity and privileged access management, the company operates in a promising market but is still expected to improve its profitability. In the health sector, Cellectis is also unveiling its annual results, after a session that saw a decline of 1.28% to 3.08 euros. The biotech pioneer in allogeneic cellular therapies remains under close scrutiny from specialized investors, particularly regarding the evolution of its cash reserves and the progress of its clinical programs. Also on the agenda today, Nyxoah. The Belgian medtech, whose stock closed at 2.685 euros in the last session, is developing a neurostimulation solution for sleep apnea and will be scrutinized for its commercial prospects. Similarly, Courtois is awaited after a marked decline of 5.00% in the last session, at 114 euros. As a confidential value on the Paris stock exchange, the private bank from Toulouse primarily attracts the interest of long-term shareholders, sensitive to the regularity of its management.
